You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recurrent Glioblastoma

Showing 1 - 25 of 8,766
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Glioblastoma Trial (Atezolizumab)

Not yet recruiting
  • Recurrent Glioblastoma
  • (no location specified)
Oct 3, 2023

Recurrent Glioblastoma Trial (fractionated radiotherapy, cadonilimab)

Not yet recruiting
  • Recurrent Glioblastoma
  • (no location specified)
Feb 20, 2023

Recurrent Glioblastoma, Glioblastoma Multiforme, GBM Trial in Charlottesville (5-ALA and Low-Intensity Focused Ultrasound (SDT))

Not yet recruiting
  • Recurrent Glioblastoma
  • +2 more
  • 5-ALA and Low-Intensity Focused Ultrasound (SDT)
  • Charlottesville, Virginia
    University of Virginia
Sep 10, 2023

Glioblastoma Multiforme, Adult, Recurrent Glioblastoma Trial in Rotterdam (Pitavastatin calcium)

Not yet recruiting
  • Glioblastoma Multiforme, Adult
  • Recurrent Glioblastoma
  • Pitavastatin calcium
  • Rotterdam, Netherlands
    Erasmus MC
Aug 3, 2023

Recurrent Glioblastoma Multiforme Trial in Beijing (SNC-109 CAR-T Cells)

Recruiting
  • Recurrent Glioblastoma Multiforme
  • SNC-109 CAR-T Cells
  • Beijing, China
    Chinese PLA General Hospital
May 11, 2023

Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,

Active, not recruiting
  • Giant Cell Glioblastoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Jan 4, 2023

Recurrent Glioblastoma Trial in Brussels (Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV,

Not yet recruiting
  • Recurrent Glioblastoma
  • Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV
  • +2 more
  • Brussels, Belgium
    UZ Brussel
Oct 23, 2023

Recurrent Glioblastoma Trial (Niraparib, Re-irradiation (re-RT))

Not yet recruiting
  • Recurrent Glioblastoma
  • (no location specified)
Dec 23, 2022

Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)

Recruiting
  • Glioma
  • +7 more
  • Laparoscopically harvested omental tissue autograft
  • New York, New York
    Lenox Hill Brain Tumor Center
Jul 31, 2023

Glioblastoma Trial (Tislelizumab and Bevacizumab)

Not yet recruiting
  • Glioblastoma
  • Tislelizumab and Bevacizumab
  • (no location specified)
Apr 12, 2023

Recurrent Glioblastoma Trial (Sintilimab plus Bevacizumab and Temozolomide)

Not yet recruiting
  • Recurrent Glioblastoma
  • Sintilimab plus Bevacizumab and Temozolomide
  • (no location specified)
Nov 27, 2022

Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (other, biological, procedure)

Active, not recruiting
Has Results
  • Recurrent Glioblastoma
  • Recurrent Gliosarcoma
  • Laboratory Biomarker Analysis
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 19, 2022

Glioblastoma Trial in Louisville (Pembrolizumab and Temozolomide)

Recruiting
  • Glioblastoma
  • Pembrolizumab and Temozolomide
  • Louisville, Kentucky
    James Graham Brown Cancer Ctr.
Jan 18, 2023

Recurrent Glioblastoma Trial in Houston (Pembrolizumab, Exablate MRgFUS + neoadjuvant pembolizumab)

Not yet recruiting
  • Recurrent Glioblastoma
  • Houston, Texas
    M D Anderson Cancer Center
May 18, 2023

Glioblastoma Trial (plasma collection)

Not yet recruiting
  • Glioblastoma
  • plasma collection
  • (no location specified)
Aug 18, 2023

Recurring Glioblastoma Trial in Fujian (Recombinant L-IFN adenovirus injection)

Recruiting
  • Recurring Glioblastoma
  • Recombinant L-IFN adenovirus injection
  • Fujian, Fujian, China
    Binhai Hospital of Fujian Medical University
Jun 27, 2023

Glioblastoma, Recurrent Glioblastoma Trial in San Francisco (RMC-5552)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • San Francisco, California
    University of California, San Francisco
Nov 28, 2022

Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

Recruiting
  • Astrocytoma, Grades II, III and IV
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)

Active, not recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • Radiation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Recurrent Glioblastoma Trial (MTX110, Programmable pump and catheter system, Lomustine)

Recruiting
  • Recurrent Glioblastoma
  • Jacksonville, Florida
  • +1 more
Jan 26, 2023

Recurrent Glioblastoma Trial in Miami (Intensity Modulated Proton Therapy (IMPT), Bevacizumab)

Recruiting
  • Recurrent Glioblastoma
  • Miami, Florida
    University of Miami
Sep 30, 2022

Glioblastoma, Recurrent Glioblastoma Trial in Iowa City (Static Magnetic and Electric (sBE) device, Lomustine, Bevacizumab)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Static Magnetic and Electric (sBE) device
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Sep 20, 2022

Recurrent Glioblastoma Trial in Beijing (Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous

Not yet recruiting
  • Recurrent Glioblastoma
  • Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous T-lymphocytes.
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Oct 10, 2022

Recurrent Glioblastoma Trial in Zhengzhou (Tislelizumab plus Bevacizumab)

Recruiting
  • Recurrent Glioblastoma
  • Tislelizumab plus Bevacizumab
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Sep 11, 2022

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)

Active, not recruiting
  • Glioblastoma
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 16, 2022